Does CARFILZOMIB Cause Unevaluable event? 250 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 250 reports of Unevaluable event have been filed in association with CARFILZOMIB (KYPROLIS). This represents 1.2% of all adverse event reports for CARFILZOMIB.
250
Reports of Unevaluable event with CARFILZOMIB
1.2%
of all CARFILZOMIB reports
36
Deaths
56
Hospitalizations
How Dangerous Is Unevaluable event From CARFILZOMIB?
Of the 250 reports, 36 (14.4%) resulted in death, 56 (22.4%) required hospitalization, and 4 (1.6%) were considered life-threatening.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 250 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which CARFILZOMIB Alternatives Have Lower Unevaluable event Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL